In light of this, we investigated if the cytotoxic advantage of IL-2/IL-15-expanded Vγ9Vδ2 T cells was maintained in hypoxia, a state more representative of the tumor microenvironment in vivo. The gene discussed is IL2; the disease is neoplasm.